Pharmafile Logo

Havas Lynx

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the better. Great talent. Great ideas. Great outcomes.

Our health is one of the most important things we have and, as a global healthcare communications agency, we see it as our role to help people make the best of their health.

We don’t just measure success in sales. We measure it in improved adherence to treatment plans, in fewer readmissions to hospital, and in better outcomes.

To us, success means more time spent with loved ones, more ambitions achieved, and more limits stretched – ultimately, more lives lived to their fullest.

We work alongside healthcare professionals, patients, carers, and pharmaceutical brands to overcome the complex challenges of modern healthcare. Our work blends strategic insight and deep scientific understanding with creativity and digital innovation, to deliver healthcare campaigns and solutions that really make a difference to people’s lives.

, 52 Princess Street, Manchester, M1 6JX

- PMLiVE- PMLiVE- PMLiVE- PMLiVE- PMLiVE- PMLiVE- PMLiVE

Our industry recognition isn’t a recent phenomenon; for more than 30 years we have repeatedly been acknowledged for our best-in-class campaigns, collecting over 150 awards for life-changing work. In 2018, we were extremely proud to have collected the esteemed Cannes Lions Healthcare Agency of the Year.

Part of the global network, Havas Health and You

We are specialists in developing brands and building relationships, combining science, strategy, creativity and technology. Our work makes a difference for patients and delivers commercial success for brands.

Our services include:

  • Advertisement, promotional and sales material
  • Global campaign development
  • Domestic, regional and global capabilities
  • Brand strategy and positioning
  • Integrated multi-channel communications
  • Patient support programmes
  • Capability building and education
  • Medical communications
  • Data, media and search
  • Disease awareness and patient activation

Havas Lynx Group launches proprietary data product to drive meaningful change across pharma

Leading global healthcare communications agency, Havas Lynx Group, has launched its proprietary data platform, Point.1, to help pharmaceutical companies to gain a deeper understanding of healthcare professionals (HCPs) to drive...

THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide

The campaign encourages people who use drugs to do something remarkable – save a life

Andi Goes – the children’s book that helps detect early signs of dyslexia

Havas Lynx Group have launched a children’s book aimed at raising awareness and detecting early signs of dyslexia. Helping to make sure that parents have the support they need whilst...

Neurofibromatosis: a condition that’s hard to say, but even harder to live with

The Childhood Tumour Trust and Havas Lynx Group have launched a campaign to raise awareness and funds for people living with a rare genetic condition, neurofibromatosis 1 (NF1).

Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond

Havas Health & You (HH&Y) have launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study which focuses on documenting the ongoing evolution of...

Havas Lynx Group elevates Jon Chapman and Paul Kinsella to CCOs

Havas Lynx Group announces the promotion of Jon Chapman and Paul Kinsella from Executive Creative Directors (ECD) to Chief Creative Officers (CCO) for Havas Lynx Group.

Elizabeth Egan appointed President of Havas Lynx Group

Europe’s largest healthcare communications agency has appointed a new President to help it build on a record year.

Havas Lynx Group lifts a silver Cannes Lion with landmark HIV campaign

Communicating a landmark moment for the HIV community has helped a leading healthcare communications agency secure another award at the famous Cannes Lions International Festival of Creativity.

Havas Lynx shines a spotlight on carers

Manchester based healthcare communications agency, Havas lynx, has launched its annual white paper campaign, which this year promotes the vital need to support the growing number of carers in our...

Healing the Healers

Because if we do not heal the healers, who is going to heal us?

Media Means Business

Creating meaningful media experiences in pharma

19 Patient Centricity on Trial

Clinical trials are broken and only patients can help us fix them. If we let them.

04 A Healthy Ambience

Creating a Lifeline to the New Digital User

03 Health Services

How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation

18 SWITCHED ONcology: The Big Communication

Matching unprecedented clinical advances in immuno-oncology with transformative communication

17 In Search of the Invisible Army

The caregivers' story

16 Generation Now

The impact of the millennial healthcare professional on our world

Patient Centricity On Trial

Today, 40 million patients are needed for over 300,00 clinical trials, worldwide. This year’s white paper explores how bringing the patient experience front and centre in clinical trials could revolutionise...

SWITCHED ONcology. Healthcare Professionals Focus Group Highlights. www.switchedoncology.com

On 16th April we met with a group of leading healthcare professionals and technology experts to learn more about how the new wave of cancer treatments are affecting everyday practice...

SWITCHED ONcology. Healthcare Professional Experience Focus Group. www.switchedoncology.com

On 16th April we met with a group of leading healthcare professionals and technology experts to learn more about how the new wave of cancer treatments are affecting everyday practice...

SWITCHED ONcology. Caregivers Focus Group Full Discussion. www.switchedoncology.com

On 8th March 2018, we held our oncology caregivers focus group to discuss the role of a cancer caregiver in today's care continuum, the challenges they face and potential solutions...

SWITCHED ONcology. Caregivers Focus Group Highlights. www.switchedoncology.com

On 8th March 2018, we held our oncology caregivers focus group to discuss the role of a cancer caregiver in today's care continuum, the challenges they face and potential solutions...

Alex Okada

Alex Okada
Chief Creative Officer

Vikki Ward

Vikki Ward
Chief Production Officer

Vernon Bainton

Vernon Bainton
Chief Medical Officer

Neil Martin

Neil Martin
Executive Advisor

David Whittingham

David Whittingham
Executive Advisor

Dan Weaden

Dan Weaden
Partner, Chief Client Officer, Havas Lynx Group

Claire Knapp

Claire Knapp
CEO, Havas Lynx Group

  • AbbVie
  • ALK
  • Astellas
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • BI
  • BMS
  • Celgene
  • Sanofi Genzyme
  • Grϋnenthal
  • Janssen
  • Lilly
  • Lundbeck
  • Merck Serono
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sanofi
  • Siemens
  • Teva
  • UCB
  • ViiV

Company Details

 Latest Content from  Havas Lynx 

Havas Lynx Group launches proprietary data product to drive meaningful change across pharma

Leading global healthcare communications agency, Havas Lynx Group, has launched its proprietary data platform, Point.1, to help pharmaceutical companies to gain a deeper understanding of healthcare professionals (HCPs) to drive...

Healing the Healers

Because if we do not heal the healers, who is going to heal us?

THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide

The campaign encourages people who use drugs to do something remarkable – save a life

Andi Goes – the children’s book that helps detect early signs of dyslexia

Havas Lynx Group have launched a children’s book aimed at raising awareness and detecting early signs of dyslexia. Helping to make sure that parents have the support they need whilst...

Neurofibromatosis: a condition that’s hard to say, but even harder to live with

The Childhood Tumour Trust and Havas Lynx Group have launched a campaign to raise awareness and funds for people living with a rare genetic condition, neurofibromatosis 1 (NF1).

Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond

Havas Health & You (HH&Y) have launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study which focuses on documenting the ongoing evolution of...

Media Means Business

Creating meaningful media experiences in pharma

Havas Lynx Group elevates Jon Chapman and Paul Kinsella to CCOs

Havas Lynx Group announces the promotion of Jon Chapman and Paul Kinsella from Executive Creative Directors (ECD) to Chief Creative Officers (CCO) for Havas Lynx Group.